B2M and neoplasm: Similarly, B2M (Beta-2-Microglobulin) is associated with worse OS and disease-specific survival (DSS) in SKCM, acting as a hazardous factor by contributing to tumor progression and immune evasion (Zhang H. et al., 2021).